Evidence map›Paper›PMID 34374466›Full record

ArticleAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2022

"This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine.

Elizabeth M Schoenfeld, William E Soares, Emily M Schaeffer, Jacob Gitlin, Kimberly Burke, Lauren M Westafer

Open access · bronzeAbstract read
In one paragraph

Article in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Induction of Medication for Opioid Use Disorder in Primary Care.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2023
    Article
  13. Article
  14. Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2023
    Article
  15. Article
  16. "Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elizabeth M SchoenfeldDepartment of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.ORCID 0000-0003-3661-4023
William E SoaresDepartment of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.ORCID 0000-0003-0760-7027
Emily M SchaefferDepartment of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.
Jacob GitlinDepartment of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.
Kimberly BurkeDepartment of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.
Lauren M WestaferDepartment of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts, USA.ORCID 0000-0003-2292-045X
Baystate Medical Center · US

Funding

K12 Cardiopulmonary Implementation Science Scholars ProgramK12HL138049 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEMON, STEPHENIE C., LINDENAUER, PETER KYLE · 2017 to 2021
$2.7M
Prevention And Control of Cancer: Training for Change in Individuals and SystemsT32CA172009 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEMON, STEPHENIE C., OCKENE, JUDITH K · 2019 to 2023
$1.5M
SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency RoomK08DA045933 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI SOARES, WILLIAM EDWARD · 2018 to 2022
$930k
Shared Decision-Making for the Promotion of Patient-Centered Imaging in the Emergency Department: Suspected Kidney StonesK08HS025701 · AHRQ · BAYSTATE MEDICAL CENTER, INC. · PI SCHOENFELD, ELIZABETH MAE · 2018 to 2022
$734k
AHRQ HHS 1K08HS025701-01A1AHRQ HHS K08 HS025701NCI NIH HHS T32 CA172009NHLBI NIH HHS K12 HL138049NIDA NIH HHS 1K08DA045933-01NIDA NIH HHS K08 DA045933
6 · The paper itself

Abstract

objectivesDespite evidence demonstrating the safety and efficacy of buprenorphine for the treatment of emergency department (ED) patients with opioid use disorder (OUD), incorporation into clinical practice has been highly variable. We explored barriers and facilitators to the prescription of buprenorphine, as perceived by practicing ED clinicians.

methodsWe conducted semistructured interviews with a purposeful sample of ED clinicians. An interview guide was developed using the Consolidated Framework for Implementation Research and Theoretical Domains Framework implementation science frameworks. Interviews were recorded, transcribed, and analyzed in an iterative process. Emergent themes were identified, discussed, and organized.

resultsWe interviewed 25 ED clinicians from 11 states in the United States. Participants were diverse with regard to years in practice and practice setting. While outer setting barriers such as the logistic costs of getting a DEA-X waiver and lack of clear follow-up for patients were noted by many participants, individual-level determinants driven by emotion (stigma), beliefs about consequences and roles, and knowledge predominated. Participants' responses suggested that implementation strategies should address stigma, local culture, knowledge gaps, and logistic challenges, but that a particular order to addressing barriers may be necessary.

conclusionsWhile some participants were hesitant to adopt a "new" role in treating patients with medications for OUD, many already had and gave concrete strategies regarding how to encourage others to embrace their attitude of "this is part of emergency medicine now."

Indexed as

BuprenorphineEmergency MedicineOpioid-Related DisordersEmergency Service, HospitalHumansUnited StatesBuprenorphinebarriersbuprenorphinefacilitatorsimplementationMOUDOUDqualitative

Identifiers

PMID34374466
PMCPMC8842516
OpenAlexW3192540497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.